GB2564444B - Liquid pharmaceutical composition of flecainide - Google Patents
Liquid pharmaceutical composition of flecainide Download PDFInfo
- Publication number
- GB2564444B GB2564444B GB1711091.7A GB201711091A GB2564444B GB 2564444 B GB2564444 B GB 2564444B GB 201711091 A GB201711091 A GB 201711091A GB 2564444 B GB2564444 B GB 2564444B
- Authority
- GB
- United Kingdom
- Prior art keywords
- flecainide
- pharmaceutical composition
- liquid pharmaceutical
- liquid
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1711091.7A GB2564444B (en) | 2017-07-10 | 2017-07-10 | Liquid pharmaceutical composition of flecainide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1711091.7A GB2564444B (en) | 2017-07-10 | 2017-07-10 | Liquid pharmaceutical composition of flecainide |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201711091D0 GB201711091D0 (en) | 2017-08-23 |
GB2564444A GB2564444A (en) | 2019-01-16 |
GB2564444B true GB2564444B (en) | 2020-09-16 |
Family
ID=59676702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1711091.7A Active GB2564444B (en) | 2017-07-10 | 2017-07-10 | Liquid pharmaceutical composition of flecainide |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2564444B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019183470A2 (en) | 2018-03-22 | 2019-09-26 | Incarda Therapeutics, Inc. | A novel method to slow ventricular rate |
US11020384B2 (en) | 2019-08-01 | 2021-06-01 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
AU2020323594B2 (en) * | 2019-08-01 | 2022-02-03 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
-
2017
- 2017-07-10 GB GB1711091.7A patent/GB2564444B/en active Active
Non-Patent Citations (7)
Title |
---|
American Journal of Health-System Pharmacy, vol. 53, no. 18, 1996, pages 2179-2184 * |
European Journal of Clinical Pharmacology, vol. 60, no. 10, 2004, pages 693-701 * |
MEDA PHARMACEUTICALS, 2017, Technical Information Leaflet for Patients Tambocor 10 mg/mL solution for injection or infusion, www.medicines.org.uk, [online], Available from https://www.medicines.org.uk/emc/files/pil.1544.pdf [Accessed 28 March 2018] * |
ORTHO-McNEIL-JANSSEN PHARMACEUTICALS, 2009, Propulsid - FDA prescribing information, side effects and uses, www.drugs.com, [online], Available from https://www.drugs.com/pro/propulsid.html [Accessed 28 March 2018] * |
U.S. Pharmacopeia, 2010, "Vehicle for Oral Solution, Sugar Free", www.pharmacopeia.cn, [online], Available from https://web.archive.org/web/20101127111557/http://www.pharmacopeia.cn/v29240/usp29nf24s0_m383.html [Accessed 28 March 2018] * |
U.S. Pharmacopeia, 2014, "Flecainide Acetate Oral Suspension", www.drugfuture.com, [online], Available from https://web.archive.org/web/20140911000345/http://www.drugfuture.com/Pharmacopoeia/USP35/data/v35300/usp35nf30s0_m3930.html [Accessed 28 March 2018] * |
University of Michigan College of Pharmacy, 2016, "Michigan Collaborative Standardization of Compounded Oral Liquids: Flecainide Acetate", www.mipedscompounds.org, [online], * |
Also Published As
Publication number | Publication date |
---|---|
GB201711091D0 (en) | 2017-08-23 |
GB2564444A (en) | 2019-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282481A (en) | Liquid pharmaceutical composition | |
ZA201901590B (en) | Liquid pharmaceutical composition | |
IL287947A (en) | Reducing viscosity of pharmaceutical formulations | |
ZA201901736B (en) | Liquid pharmaceutical composition | |
IL277241A (en) | Liquid pharmaceutical composition | |
HK1257026A1 (en) | Liquid pharmaceutical composition | |
ZA201907313B (en) | Stable liquid pharmaceutical composition | |
GB2548424B (en) | Liquid pharmaceutical composition of clonidine | |
ZA201807125B (en) | Pharmaceutical composition of dapagliflozin | |
GB2564444B (en) | Liquid pharmaceutical composition of flecainide | |
GB201718468D0 (en) | Stable liquid pharmaceutical compositions of bortezomb | |
HK1244685A1 (en) | Liquid pharmaceutical composition | |
IL253572A0 (en) | Liquid pharmaceutical composition |